Xenon Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:XENE) | MetaTrader

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Total assets 835.9 M798.14 M743.28 M674.28 M607.84 M633.16 M Total liabilities 38.09 M43.24 M39.32 M40.3 M48.33 M51.4 M Total equity 797.81 M754.9 M703.96 M633.98 M559.51 M581.76 M Total liabilities & shareholders' equities 835.9 M798.14 M743.28 M674.28 M607.84 M633.16 M Total debt —————— Net debt ——————

Новости

Alibaba Earnings, Jobs Data

Акции Xenon Pharmaceuticals достигли 52-недельного максимума

Xenon Pharmaceuticals stock hits 52-week high at $46.68

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Отчетность Xenon на фоне ожиданий ключевых данных фазы 3

Xenon earnings loom as investors brace for Phase 3 catalyst

Wolfe Research начинает покрытие акций Xenon Pharmaceuticals с рейтингом Outperform

Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

Stifel повышает целевую цену акций Xenon Pharmaceuticals до $66

Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential

Biohaven: RBC Capital повысил рейтинг акций на фоне данных ЦНС